Asam amino rantai cabang terhadap status gizi, dan perubahan metabolik pada penyakit hati: Sebuah tinjauan sistematis

Author(s): Carissa Wityadarda, Ester Hanantika Immanuella, Fernando Diaz Ndopo, Teresa Ester, Sarah Damayanti Siregar, Yuli Berliana
DOI: 10.30867/gikes.v6i3.2407

Abstract

Background: Liver diseases such as non-alcoholic fatty liver disease (NAFLD) and cirrhosis are influenced by factors like viral infections, alcohol, immune dysfunction, genetic predisposition, and metabolic factors. Branched-chain amino acids (BCAAs)—leucine, isoleucine, and valine—are vital for protein metabolism and liver function. The role of BCAAs in liver disease and metabolic changes requires further study.

Objectives:  To evaluate the role of BCAAs in nutritional status and metabolic changes in liver disease through a systematic review.

Methods: A systematic review was conducted following the PRISMA protocol. Literature was searched on Google Scholar for publications from 2019 to 2024. Studies were selected based on inclusion and exclusion criteria. Descriptive analysis summarized the findings, and statistical tests evaluated the relationship between BCAA consumption or supplementation and liver disease progression.

Results: Eight studies met the inclusion criteria. High BCAA consumption was associated with an increased risk of NAFLD (OR = 1,32, p < 0,001). In contrast, BCAA supplementation improved MELD and CP scores in cirrhotic patients. Elevated BCAA levels were also linked to a higher risk of type 2 diabetes (OR = 1,60, 95% CI = 1,14-2,23, p = 0,006).

Conclusions: BCAA supplementation may help slow cirrhosis progression and improve sarcopenia and liver function. However, its use should be tailored to avoid adverse effects. More research is needed to explore long-term effects on liver disease.

Keywords

Branched-chain amino acids, nutritional status, obesity, and liver

Full Text:

PDF

References

Böhler, M., van den Berg, E. H., Almanza, M. C. T., Connelly, M. A., Bakker, S. J. L., de Meijer, V. E., Dullaart, R. P. F., Blokzijl, H., Hak, E., Hepkema, B. G., Klont, F., Knobbe, T. J., Kremer, D., Leuvenink, H. G. D., Lexmond, W. S., Niesters, H. G. M., van Pelt, L. J., Pol, R. A., Porte, R. J., … Weersma, R. K. (2022a). Branched chain amino acids are associated with metabolic complications in liver transplant recipients. Clinical Biochemistry, 102(December 2021), 26–33. https://doi.org/10.1016/j.clinbiochem.2022.01.009

Böhler, M., van den Berg, E. H., Almanza, M. C. T., Connelly, M. A., Bakker, S. J. L., de Meijer, V. E., Dullaart, R. P. F., Blokzijl, H., Hak, E., Hepkema, B. G., Klont, F., Knobbe, T. J., Kremer, D., Leuvenink, H. G. D., Lexmond, W. S., Niesters, H. G. M., van Pelt, L. J., Pol, R. A., Porte, R. J., … Weersma, R. K. (2022b). Branched chain amino acids are associated with metabolic complications in liver transplant recipients. Clinical Biochemistry, 102(January), 26–33. https://doi.org/10.1016/j.clinbiochem.2022.01.009

Daftari, G., Tehrani, A. N., Pashayee-khamene, F., Karimi, S., Ahmadzadeh, S., Hekmatdoost, A., Salehpour, A., Saber-Firoozi, M., Hatami, B., & Yari, Z. (2023). Dietary protein intake and mortality among survivors of liver cirrhosis: a prospective cohort study. BMC Gastroenterology, 23(1), 1–11. https://doi.org/10.1186/s12876-023-02832-1

Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023). Global burden of liver disease: 2023 update. In Journal of Hepatology (Vol. 79, Issue 2, pp. 516–537). Elsevier B.V. https://doi.org/10.1016/j.jhep.2023.03.017

Dimou, A., Tsimihodimos, V., & Bairaktari, E. (2022). The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human Pathophysiology. International Journal of Molecular Sciences, 23(7). https://doi.org/10.3390/ijms23074022

Espina, S., Gonzalez-Irazabal, Y., Sanz-Paris, A., Lopez-Yus, M., Garcia-Sobreviela, M. P., Moral-Bergos, R. Del, Garcia-Rodriguez, B., Fuentes-Olmo, J., Bernal-Monterde, V., & Arbones-Mainar, J. M. (2021). Amino acid profile in malnourished patients with liver cirrhosis and its modification with oral nutritional supplements: Implications on minimal hepatic encephalopathy. Nutrients, 13(11). https://doi.org/10.3390/nu13113764

Farra, S. D. (2023a). Acute consumption of a branched chain amino acid and vitamin B-6 containing sports drink does not improve multiple sprint exercise performance, but increases post-exercise blood glucose. Frontiers in Nutrition, 10(1), 1–10. https://doi.org/10.3389/fnut.2023.1266422

Farra, S. D. (2023b). Acute consumption of a branched chain amino acid and vitamin B-6 containing sports drink does not improve multiple sprint exercise performance, but increases post-exercise blood glucose. Frontiers in Nutrition, 10(December). https://doi.org/10.3389/fnut.2023.1266422

Gojda, J., & Cahova, M. (2021). Gut microbiota as the link between elevated bcaa serum levels and insulin resistance. Biomolecules, 11(10). https://doi.org/10.3390/biom11101414

Guo, X., Yin, X., Liu, Z., & Wang, J. (2022). Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. International Journal of Molecular Sciences, 23(24). https://doi.org/10.3390/ijms232415489

Ismaiel, A., Bucsa, C., Farcas, A., Leucuta, D. C., Popa, S. L., & Dumitrascu, D. L. (2022). Effects of Branched-Chain Amino Acids on Parameters Evaluating Sarcopenia in Liver Cirrhosis: Systematic Review and Meta-Analysis. Frontiers in Nutrition, 9 (January). https://doi.org/10.3389/fnut.2022.749969

Khruomo, V., Reema, N., Singh, K. R., & Singh, T. G. (2020). “ Role of oral supplementation of branched chain amino acids in the outcome of compensated alcoholic cirrhosis of liver . .” 19(12), 29–35. https://doi.org/10.9790/0853-1912052935

Lai, J. C., Tandon, P., Bernal, W., Tapper, E. B., Ekong, U., Dasarathy, S., & Carey, E. J. (2021). Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology, 74(3), 1611–1644. https://doi.org/10.1002/hep.32049

Lischka, J., Schanzer, A., Hojreh, A., Ba Ssalamah, A., Item, C. B., de Gier, C., Walleczek, N. K., Metz, T. F., Jakober, I., Greber-Platzer, S., & Zeyda, M. (2021). A branched-chain amino acid-based metabolic score can predict liver fat in children and adolescents with severe obesity. Pediatric Obesity, 16(4). https://doi.org/10.1111/ijpo.12739

Lo, E. K. K., Felicianna, Xu, J. H., Zhan, Q., Zeng, Z., & El-Nezami, H. (2022). The Emerging Role of Branched-Chain Amino Acids in Liver Diseases. In Biomedicines (Vol. 10, Issue 6). MDPI. https://doi.org/10.3390/biomedicines10061444

López-González, Á. A., Jané, B. A., Comas, L. M., Bote, S. A., Miguel, H. M. G. S., & Manent, J. I. R. (2022). Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study. Nutrients, 14(14). https://doi.org/10.3390/nu14142795

Mokhtari, E., Ahmadirad, H., Teymoori, F., Mohammadebrahim, A., Bahrololomi, S. S., & Mirmiran, P. (2022). The association between dietary amino acids and the risk of nonalcoholic fatty liver disease among Tehranian adults: a case-control study. BMC Nutrition, 8(1), 1–8. https://doi.org/10.1186/s40795-022-00656-y

Park, J. G., Tak, W. Y., Park, S. Y., Kweon, Y. O., Chung, W. J., Jang, B. K., Bae, S. H., Lee, H. J., Jang, J. Y., Suk, K. T., Oh, M. J., Heo, J., Woo, H. Y., Jang, S. Y., Lee, Y. R., Lee, J. S., Kim, D. Y., Kim, S. H., Suh, J. I., … Lee, W. K. (2020). Effects of branched-chain amino acid (BCAA) supplementation on the progression of advanced liver disease: A korean nationwide, multicenter, prospective, observational, cohort study. Nutrients, 12(5). https://doi.org/10.3390/nu12051429

Reifenberg, P., & Zimmer, A. (2024). Branched-chain amino acids: physico-chemical properties, industrial synthesis and role in signaling, metabolism and energy production. In Amino Acids (Vol. 56, Issue 1). Springer. https://doi.org/10.1007/s00726-024-03417-2

Setiawan, D., Arisandi, D., & Trisnawati, L. (2022). Aplikasi Prediksi Penyakit Sirosis Hati Menggunakan Algoritma Genetika (Vol. 2, Issue 1). https://doi.org/DOI: https://doi.org/10.58794/santi.v2i 1.54

Silaban, B. P., Lumongga, F., & Silitonga, H. (2020). Karakteristik Penderita Sirosis Hati Characteristics of People with Liver Cirrhosis. Jurnal Kedokteran Methodist, 13(2). https://ejurnal.methodist.ac.id/index.php/jkm/article/view/1322

Singh Tejavath, A., Mathur, A., Nathiya, D., Singh, P., Raj, P., Suman, S., Mundada, P. R., Atif, S., Rai, R. R., & Tomar, B. S. (2021). Impact of Branched Chain Amino Acid on Muscle Mass, Muscle Strength, Physical Performance, Combined Survival, and Maintenance of Liver Function Changes in Laboratory and Prognostic Markers on Sarcopenic Patients With Liver Cirrhosis (BCAAS Study): A Rando. Frontiers in Nutrition, 8(September). https://doi.org/10.3389/fnut.2021.715795

Wali, J. A., Solon-Biet, S. M., Freire, T., & Brandon, A. E. (2021). Macronutrient determinants of obesity, insulin resistance and metabolic health. In Biology (Vol. 10, Issue 4). MDPI AG. https://doi.org/10.3390/biology10040336

Yanti, R., Angkasa, D., & Jus’, I. (2021). Pengembangan Produk Snack Bar Tinggi BCAA [Branched-chain. 44(1). https://doi.org/DOI: https://doi.org/10.22435/pgm.v44i1.3968

Younossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., & Henry, L. (2023). The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology, 77(4), 1335–1347. https://doi.org/10.1097/HEP.0000000000000004.

DOI: http://dx.doi.org/10.30867/gikes.v6i3.2407

Refbacks

  • There are currently no refbacks.